E-cigarettes greatly raise risk of chronic lung disease
The free daily newsletter covering the top cardiovascular headlines
Related Articles
TAVR patients with moderate or greater TR may face increased risks
When TAVR patients present with moderate or greater tricuspid regurgitation, it could impact the care team’s treatment strategy of choice.
American College of Cardiology now supports early use of medication to treat obesity
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles…
American College of Cardiology now supports early use of medication to treat obesity
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles…
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.
AMA agrees to help after initial request for an independent cardiovascular board was denied
After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some…
TAVR patients with moderate or greater TR may face increased risks
When TAVR patients present with moderate or greater tricuspid regurgitation, it could impact the care team’s treatment strategy of choice.
AI model gets helpful heart assessments out of nongated CT scans
“Using AI for tasks like CAC detection can help shift medicine from a reactive approach to the proactive prevention of disease,” one researcher said.
Cannabis is bad for the heart—should the risk be taken more seriously?
Use of the drug more than doubles a person’s risk of dying from heart disease, according to a new analysis of 24 different studies. In…
AI model gets helpful heart assessments out of nongated CT scans
“Using AI for tasks like CAC detection can help shift medicine from a reactive approach to the proactive prevention of disease,” one researcher said.
Dexcom recalls more than 2 million CGM receivers over safety issues—dozens of adverse events reported
There is an increased risk that these devices will not provide audible alerts for low or high blood glucose levels. The FDA has ruled that…